BERLIN (Reuters) - Genetic testing specialist Qiagen received emergency use authorization for a new coronavirus test from the U.S. drugs regulator FDA, it said on Monday.
“This polymerase chain reaction (PCR) multiplex test will be an important tool now and in upcoming winter seasons for simultaneous qualitative detection and differentiation of influenzas A and B, respiratory syncytial virus (RSV) and SARS-CoV-2 infections within 80 minutes,” the company said in a statement.
Qiagen shares rose 2.8% in early Frankfurt trade.
Reporting by Kirsti Knolle; Editing by Riham Alkousaa
"emergency" - Google News
March 29, 2021 at 02:15PM
https://ift.tt/31shdZ1
Qiagen receives FDA emergency approval for coronavirus PCR test - Reuters
"emergency" - Google News
https://ift.tt/2VVGGYQ
https://ift.tt/3d7MC6X
emergency
Bagikan Berita Ini
Amazing Post !! this is very informative post thanks for share it with us.
ReplyDeleteBook your PCR test, in which our lab technicians detect viruses using genetic material by molecular test. Make an appointment with us right now!